Betty Cabrera

Title(s), Pediatrics
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Correction: a phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic HER2-negative breast cancer. Breast Cancer Res. 2024 Mar 13; 26(1):46. Shatsky RA, Batra-Sharma H, Helsten T, Schwab RB, Pittman EI, Pu M, Weihe E, Ghia EM, Rassenti LZ, Molinolo A, Cabrera B, Breitmeyer JB, Widhopf Ii GF, Messer K, Jamieson C, Kipps TJ, Parker BA. PMID: 38481291; PMCID: PMC10938766.
      View in: PubMed   Mentions:    Fields:    
    2. A phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic Her2-negative breast cancer. Breast Cancer Res. 2024 Feb 26; 26(1):32. Shatsky RA, Batra-Sharma H, Helsten T, Schwab RB, Pittman EI, Pu M, Weihe E, Ghia EM, Rassenti LZ, Molinolo A, Cabrera B, Breitmeyer JB, Widhopf GF, Messer K, Jamieson C, Kipps TJ, Parker BA. PMID: 38408999; PMCID: PMC10895766.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    3. Influence of race on microsatellite instability and CD8+ T cell infiltration in colon cancer. PLoS One. 2014; 9(6):e100461. Carethers JM, Murali B, Yang B, Doctolero RT, Tajima A, Basa R, Smith EJ, Lee M, Janke R, Ngo T, Tejada R, Ji M, Kinseth M, Cabrera BL, Miyai K, Keku TO, Martin CF, Galanko JA, Sandler RS, McGuire KL. PMID: 24956473; PMCID: PMC4067325.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansCells
    4. Pharmacokinetics of cysteamine bitartrate following intraduodenal delivery. Fundam Clin Pharmacol. 2014 Apr; 28(2):136-43. Dohil R, Cabrera BL, Gangoiti JA, Barshop BA, Rioux P. PMID: 23113697.
      View in: PubMed   Mentions: 8     Fields:    Translation:Animals
    5. The Effect of Food on Cysteamine Bitartrate Absorption in Healthy Participants. Clin Pharmacol Drug Dev. 2012 Oct; 1(4):170-4. Dohil R, Cabrera BL, Gangoiti J, Rioux P. PMID: 27121459.
      View in: PubMed   Mentions: 4     Fields:    
    6. Treatment of cystinosis with delayed-release cysteamine: 6-year follow-up. Pediatr Nephrol. 2013 Mar; 28(3):507-10. Dohil R, Cabrera BL. PMID: 23001048.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    7. The effect of cysteamine bitartrate on adiponectin multimerization in non-alcoholic fatty liver disease and healthy subjects. J Pediatr. 2012 Oct; 161(4):639-45.e1. Dohil R, Meyer L, Schmeltzer S, Cabrera BL, Lavine JE, Phillips SA. PMID: 22633783.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    8. Both hMutSα and hMutSß DNA mismatch repair complexes participate in 5-fluorouracil cytotoxicity. PLoS One. 2011; 6(12):e28117. Tajima A, Iwaizumi M, Tseng-Rogenski S, Cabrera BL, Carethers JM. PMID: 22164234; PMCID: PMC3229514.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    9. Expression of GIV/Girdin, a metastasis-related protein, predicts patient survival in colon cancer. FASEB J. 2011 Feb; 25(2):590-9. Garcia-Marcos M, Jung BH, Ear J, Cabrera B, Carethers JM, Ghosh P. PMID: 20974669; PMCID: PMC3023389.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCells
    10. Relationship of EMAST and microsatellite instability among patients with rectal cancer. J Gastrointest Surg. 2010 Oct; 14(10):1521-8. Devaraj B, Lee A, Cabrera BL, Miyai K, Luo L, Ramamoorthy S, Keku T, Sandler RS, McGuire KL, Carethers JM. PMID: 20844976; PMCID: PMC2943582.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansCells
    11. Pharmacokinetics of enteric-coated cysteamine bitartrate in healthy adults: a pilot study. Br J Clin Pharmacol. 2010 Sep; 70(3):376-82. Gangoiti JA, Fidler M, Cabrera BL, Schneider JA, Barshop BA, Dohil R. PMID: 20716238; PMCID: PMC2949910.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    12. A G{alpha}i-GIV molecular complex binds epidermal growth factor receptor and determines whether cells migrate or proliferate. Mol Biol Cell. 2010 Jul 01; 21(13):2338-54. Ghosh P, Beas AO, Bornheimer SJ, Garcia-Marcos M, Forry EP, Johannson C, Ear J, Jung BH, Cabrera B, Carethers JM, Farquhar MG. PMID: 20462955; PMCID: PMC2893996.
      View in: PubMed   Mentions: 95     Fields:    Translation:HumansCells
    13. Long-term treatment of cystinosis in children with twice-daily cysteamine. J Pediatr. 2010 May; 156(5):823-7. Dohil R, Gangoiti JA, Cabrera BL, Fidler M, Schneider JA, Barshop BA. PMID: 20138296.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    14. RAS/ERK modulates TGFbeta-regulated PTEN expression in human pancreatic adenocarcinoma cells. Carcinogenesis. 2007 Nov; 28(11):2321-7. Chow JY, Quach KT, Cabrera BL, Cabral JA, Beck SE, Carethers JM. PMID: 17638924; PMCID: PMC4151289.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    15. Activin type 2 receptor restoration in MSI-H colon cancer suppresses growth and enhances migration with activin. Gastroenterology. 2007 Feb; 132(2):633-44. Jung BH, Beck SE, Cabral J, Chau E, Cabrera BL, Fiorino A, Smith EJ, Bocanegra M, Carethers JM. PMID: 17258738; PMCID: PMC4154562.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    16. Bone morphogenetic protein signaling and growth suppression in colon cancer. Am J Physiol Gastrointest Liver Physiol. 2006 Jul; 291(1):G135-45. Beck SE, Jung BH, Fiorino A, Gomez J, Rosario ED, Cabrera BL, Huang SC, Chow JY, Carethers JM. PMID: 16769811; PMCID: PMC4138725.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCells
    17. The mismatch repair complex hMutS alpha recognizes 5-fluorouracil-modified DNA: implications for chemosensitivity and resistance. Gastroenterology. 2004 Dec; 127(6):1678-84. Tajima A, Hess MT, Cabrera BL, Kolodner RD, Carethers JM. PMID: 15578504.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansCells
    18. Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer. Gastroenterology. 2004 Feb; 126(2):394-401. Carethers JM, Smith EJ, Behling CA, Nguyen L, Tajima A, Doctolero RT, Cabrera BL, Goel A, Arnold CA, Miyai K, Boland CR. PMID: 14762775.
      View in: PubMed   Mentions: 191     Fields:    Translation:HumansCells
    Betty's Networks
    Concepts (143)
    Derived automatically from this person's publications.
    _
    Co-Authors (23)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _